Get startedLog in
    Picture of Hyloris Pharmaceuticals SA logo

    HYL — Hyloris Pharmaceuticals SA News Story

    0.000.00%
    be flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapNeutral
    All News

    Brief: Hyloris Announces Earlier Than Expected PDUFA Date For Maxigesic® IV

    Picture of Hyloris Pharmaceuticals SA logoHyloris Pharmaceuticals SA
    15/11/2021 06:08
    Nov 15 (Reuters) - HYLORIS PHARMACEUTICALS SA  HYL.BR :
    * REG-HYLORIS ANNOUNCES EARLIER THAN EXPECTED PDUFA DATE FOR
MAXIGESIC® IV
    * (FDA) HAS SET PRESCRIPTION DRUG USER FEE ACT DATE (PDUFA)
FOR
NEW DRUG APPLICATION (NDA) FOR MAXIGESIC® IV ON 30 JUNE 2022

Source text for Eikon:  ID:nGNE5tcnl2 
Further company coverage:  HYL.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Hyloris Pharmaceuticals SA

    See all news